Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
9.26
-0.48 (-4.93%)
At close: Sep 15, 2025, 4:00 PM EDT
9.31
+0.05 (0.54%)
After-hours: Sep 15, 2025, 4:00 PM EDT
Exagen Market Cap
Exagen has a market cap or net worth of $204.85 million as of September 15, 2025. Its market cap has increased by 292.75% in one year.
Market Cap
204.85M
Enterprise Value
200.12M
1-Year Change
292.75%
Ranking
Category
Stock Price
$9.26
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $204.85M, an increase of 224.62%. That is a compound annual growth rate of 21.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 214.32M | 196.37% |
| Dec 31, 2024 | 72.31M | 113.18% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | 167.01M | -47.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |